You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Recent Transactions
Investors

Nusirt Sciences, Inc.

Overview

Headquarters
3835 Cleghorn Avenue Suite 200 Nashville Tn 37215
Employees (Worldwide)
1 - 10
Industries
Food

Holding Companies

Pharmaceuticals

Medical Support Services

Biotechnology
Company Description
Nusirt Sciences, Inc manufactures food ingredients for healthcare markets. It has technology platform that uses a patented combination of leucine, an essential amino acid, and existing human medicines targeted at diseases that may be addressed by activating sirtuin pathways. The company was founded by Michael Zemel in 2007 and is headquartered in Nashville, TN.
Website

In The News See More

Business Wire
October 23, 2017
PR Newswire
October 16, 2017
PR Newswire
October 6, 2017
Marketwired
August 14, 2017
Marketwired
August 14, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees


Executive Chairman & President

Chief Operating Officer
See our list of current and previous employees when you upgrade.

Board of Directors


Executive Chairman & Co-Founder at Streamweaver, Inc.

Founder at Nusirt Sciences, Inc.

Co-Founder & Managing Director at TriStar Technology Ventures
See our list of current and previous board members when you upgrade.

Paths to Nusirt Sciences, Inc.

Nusirt Sciences, Inc.
You
Connections via Relationship Science
Nusirt Sciences, Inc.
Sync your contacts to see how you can connect with Nusirt Sciences, Inc..

Recent Transactions

Details Hidden
Nusirt Sciences, Inc. raised money in a private placement transaction
Details Hidden
Nusirt Sciences, Inc. raised money in a private placement transaction
Details Hidden
Nusirt Sciences, Inc. raised money in a private placement transaction

Investors

Details Hidden
TriStar Technology Ventures focuses on pre-seed and seed stage investments in the healthcare sector including healthcare information technology, healthcare services, biotechnology, pharmaceuticals, personalized medicine and medical devices companies. The firm looks for companies with: (1) protected or protectable intellectual property positions (2) addressable markets of a significant size (3) sound science with engaged inventors (4) involved individuals with domain expertise and (5) a validated unmet market need.TriStar is particularly interested in technologies and start-up companies emerging from universities and research institutions located in Tennessee. In addition, the firm invests in existing companies that will be located in Tennessee. They will also consider investments in existing companies that do not have a direct tie to a research institution but otherwise meet the firm's investment criteria.Initial investments typically range from $100,000 to $1 million, with a total investment of $1 million to $2 million over the life of the investment.
Details Hidden
Hatteras Venture Partners invests in early-stage companies focused on the following sectors: biopharmaceuticals, medical devices, diagnostics and related opportunities in human medicine. They invest in companies located in the research-driven regions of North Carolina and the Southeastern United States.
Details Hidden
Mountain Group Partners (“MGP”) is an investor dedicated to investing in and actively guiding transformational businesses in the Life Sciences and Technology sectors. Founded in 2002, MGP principals have invested in more than 30 companies in these sectors.Currently, MGP is investing funds from (1) MGC Venture Partners 2013, LP, (2) Limestone Fund, a fund chosen in 2009 by the State of Tennessee to invest state funds to drive economic growth in Tennessee, and (3) private capital accounts.Mountain Group Partners seeks to invest in seed and early stage companies focused on two major sectors: Life Sciences and Technology. Within the Life Sciences sector, the Fund primarily focuses on investments in the diagnostics, medical device, and nutraceuticals & expedited drug development sub-sectors. Within the Technology sector, the Fund has a concentration in healthcare technology, business services and consumer technology companiesMountain Group Partners seeks to invest in Small/Middle Market Companies ?MGP targets private businesses or divisions of companies typically with revenue between $1 million and $10 million•History of Cash Flow ?Acquisition candidates should have a history of strong cash flow•Quality Management Teams ?MGP seeks to partner with strong management teams that have a proven record of success and who wish to become co-owners with MGP•Basic Industries ?Manufacturing, distribution and basic service companies with strong market shares in focused niches are targeted.
Details Hidden
Founder at Nusirt Sciences, Inc.
Details Hidden
Tennessee Community Ventures (TNCV) focuses on technology transfer, seed and early stage investment opportunities. They seek to identify technologies, products and/or services that offer a unique solution to a specific point of pain or opportunity for their respective industries, lend themselves to business models that offer a clear path to profitability with modest capital needs and promote scalable cost structures that create competitive advantages. Investment opportunities are evaluated based on an ability to deliver exceptional financial returns while transforming and diversifying Tennessee's economic base through the creation of quality jobs and community wealth. They are generalists and are always interested in special situations that present unique opportunities outside their past experiences, which include technology enabled products and services, e-commerce, digital media, manufacturing, advanced materials, specialty food products, ethnic products and services, and business and retail services.TNCV has a unique partnership and direct interaction with the University of Tennessee Research Foundation and has committed significant capital to proof- of-concept investments, which are expected to range from $50,000 to $100,000. More traditional seed and early stage initial investments typically range from $250,000 to $750,000 and target the funding gap between start-up and later stage institutional venture rounds. TNCV's target investment size over the life of each portfolio company is between $1 million and $2 million. The target investment size is likely achieved through multiple rounds of investment in each portfolio company, with follow-on investments receiving the same level of diligence and scrutiny as initial investments.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.